| G051 | GL | Glycemic Load | Measure of carbohydrate impact on blood sugar. | Diet planned with low GL foods. |
| G052 | GLD | Glimepiride | Oral sulfonylurea antidiabetic drug. | GLD prescribed for type 2 diabetes. |
| G053 | GLIM | Global Leadership Initiative on Malnutrition | International malnutrition diagnostic criteria. | GLIM used for elderly patient nutrition status. |
| G054 | GLP | Glucagon-Like Peptide | Gut hormone regulating insulin. | GLP-1 analogs used in diabetes. |
| G055 | GLP-1RA | GLP-1 Receptor Agonist | Antidiabetic drug class. | GLP-1RA semaglutide prescribed. |
| G056 | GLT | Glucose Load Test | Screening for diabetes. | GLT positive at 1 hour. |
| G057 | GLU | Glucose | Blood sugar measurement. | GLU checked during hypoglycemia. |
| G058 | GM | Gray Matter / Genetically Modified | Brain tissue or biology term. | MRI showed GM atrophy. |
| G059 | GM-CSF | Granulocyte-Macrophage Colony Stimulating Factor | Cytokine stimulating WBC growth. | GM-CSF therapy for neutropenia. |
| G060 | GMA | Giant Muscle Atrophy | Severe muscle wasting. | GMA noted in ALS patient. |
| G061 | GMB | Glomerular Basement Membrane | Kidney filtration barrier. | Anti-GBM antibodies tested. |
| G062 | GMC | General Medical Council | UK regulatory body. | GMC guidelines followed. |
| G063 | GMD | Global Mental Disorder | WHO classification. | GMD prevalence studied worldwide. |
| G064 | GME | Graduate Medical Education | Postgraduate medical training. | Resident enrolled in GME. |
| G065 | GMH | Germinal Matrix Hemorrhage | Neonatal brain bleed. | Preterm infant had GMH. |
| G066 | GML | Gastric Mucosa-Associated Lymphoma | Stomach lymphoma. | GML linked to H. pylori. |
| G067 | GMR | Gentamicin Resistance | Antibiotic resistance marker. | GMR detected in E. coli. |
| G068 | GMS | Gomori Methenamine Silver | Fungal stain in pathology. | GMS stain positive for Candida. |
| G069 | GMV | Gray Matter Volume | Neuroimaging parameter. | GMV reduced in Alzheimer’s. |
| G070 | GN | Glomerulonephritis | Inflammatory kidney disease. | GN caused hematuria. |
| G071 | GNB | Gram-Negative Bacilli | Bacteria group. | Sepsis due to GNB infection. |
| G072 | GNC | Gram-Negative Cocci | Bacteria group (e.g., Neisseria). | GNC isolated from culture. |
| G073 | GNF | Granulocyte Neutrophil Function | WBC functional test. | GNF impaired in CGD. |
| G074 | GNP | Gemcitabine + Nab-Paclitaxel | Chemotherapy regimen. | GNP used in pancreatic cancer. |
| G075 | GNRH | Gonadotropin-Releasing Hormone | Hypothalamic hormone. | GnRH agonist given for prostate cancer. |
| G076 | GNS | Guillain–Barré Neurological Score | Disability grading. | GNS used for GBS prognosis. |
| G077 | GO | Glycogenolysis | Process of glycogen breakdown. | GO increased in fasting state. |
| G078 | GOF | Gain of Function | Type of genetic mutation. | GOF mutation noted in oncogene. |
| G079 | GORD | Gastro-Oesophageal Reflux Disease | UK spelling for GERD. | GORD managed with lifestyle changes. |
| G080 | GP | General Practitioner / Glycoprotein | Primary care physician or protein type. | GP referred patient to specialist. |
| G081 | GPA | Granulomatosis with Polyangiitis | Autoimmune vasculitis (Wegener’s). | GPA diagnosed via c-ANCA positivity. |
| G082 | GPC | Gram-Positive Cocci | Bacteria type. | Blood culture showed GPC. |
| G083 | GPD | Glucose-6-Phosphate Dehydrogenase | Enzyme deficiency (same as G6PD). | GPD deficiency detected. |
| G084 | GPE | General Physical Examination | Routine clinical exam. | GPE performed at admission. |
| G085 | GPI | Glycosylphosphatidylinositol | Cell surface anchor molecule. | GPI deficiency linked to PNH. |
| G086 | GPL | Glycoprotein Lipid | Cellular structure component. | GPL studied in lipid research. |
| G087 | GPO | Group Practice Office | Clinical organization type. | Patient registered under GPO. |
| G088 | GPP | Generalized Pustular Psoriasis | Severe skin condition. | GPP flare treated with cyclosporine. |
| G089 | GPR | G-Protein Coupled Receptor | Major receptor class in body. | GPR targeted by antihistamines. |
| G090 | GPS | Glutamine-Phenylalanine Substitution | Genetic mutation shorthand. | GPS mutation identified in sequencing. |
| G091 | GPT | Glutamate Pyruvate Transaminase (ALT) | Liver enzyme. | GPT elevated in hepatitis. |
| G092 | GPx | Glutathione Peroxidase | Antioxidant enzyme. | GPx reduced in oxidative stress. |
| G093 | GR | Glucocorticoid Receptor | Hormone receptor. | GR targeted in steroid therapy. |
| G094 | GRA | Glucocorticoid Remediable Aldosteronism | Rare genetic hypertension. | GRA diagnosed by genetic test. |
| G095 | GRAS | Generally Recognized As Safe | FDA food designation. | Additive labeled as GRAS. |
| G096 | GRB2 | Growth Factor Receptor-Bound Protein 2 | Signal transduction protein. | GRB2 mutation studied in leukemia. |
| G097 | GRC | General Respiratory Clinic | Pulmonary outpatient clinic. | GRC followed for asthma. |
| G098 | GRE | Gradient Echo (MRI) | Imaging sequence. | GRE used in brain MRI. |
| G099 | GRF | Growth Hormone Releasing Factor | Endocrine regulator. | GRF deficiency tested. |
| G100 | GRN | Granulin | Protein involved in cell growth. | GRN mutation in dementia. |
| G101 | GRS | Genetic Risk Score | Polygenic disease predictor. | GRS calculated for CAD. |
| G102 | GRT | Gene Replacement Therapy | Treatment approach for genetic disease. | GRT trial for hemophilia. |
| G103 | GRV | Gastric Residual Volume | Measurement in ICU for feeding tolerance. | GRV checked before enteral feed. |
| G104 | GS | Gaucher’s Spleen / General Surgery | Enlarged spleen in Gaucher’s / specialty. | GS consulted for splenectomy. |
| G105 | GSD | Glycogen Storage Disease | Inherited metabolic disorder. | GSD diagnosed in child with hepatomegaly. |
| G106 | GSE | Gene Set Enrichment | Bioinformatics analysis. | GSE used in genomics research. |
| G107 | GSH | Glutathione | Major antioxidant molecule. | GSH level measured in liver disease. |
| G108 | GSI | Gastroesophageal Symptoms Index | Reflux questionnaire tool. | GSI score elevated. |
| G109 | GSM | Genitourinary Syndrome of Menopause | Atrophy-related disorder. | GSM treated with estrogen cream. |
| G110 | GSP | Glycosylated Serum Protein | Marker of short-term glycemia. | GSP used in diabetes monitoring. |
| G111 | GSR | Galvanic Skin Response | Autonomic nervous test. | GSR applied in psychophysiology. |
| G112 | GSS | Gerstmann–Sträussler–Scheinker Disease | Rare prion disease. | GSS confirmed by genetic test. |
| G113 | GST | Glutathione S-Transferase | Detox enzyme family. | GST polymorphism studied in cancer risk. |
| G114 | GSV | Great Saphenous Vein | Largest superficial vein in leg. | Varicose veins treated by GSV ligation. |
| G115 | GT | Gene Therapy / Glucose Tolerance | Genetic treatment or metabolic test. | GT done for diabetes diagnosis. |
| G116 | GTC | Generalized Tonic-Clonic Seizure | Type of seizure. | Patient presented with GTC. |
| G117 | GTCS | Generalized Tonic-Clonic Seizures | Same as GTC, plural. | GTCS controlled with valproate. |
| G118 | GTE | Genetic Test Evaluation | Analysis of genetic risk. | GTE performed for BRCA mutation. |
| G119 | GTF | General Transcription Factor | Protein for gene expression. | GTF studied in molecular biology. |
| G120 | GTG | Glycerol-3-Phosphate Dehydrogenase Gene | Gene linked to metabolism. | GTG mutation identified. |
| G121 | GTH | Gonadotropin Hormone | Reproductive hormones (LH/FSH). | GTH measured in fertility workup. |
| G122 | GTI | Genitourinary Tract Infection | UTI or reproductive tract infection. | GTI treated with antibiotics. |
| G123 | GTL | Germinal Center T-Lymphocyte | Specialized immune cell. | GTL count reduced in lymphoma. |
| G124 | GTN | Glyceryl Trinitrate | Vasodilator drug. | GTN patch applied for angina. |
| G125 | GTP | Guanosine Triphosphate | Energy nucleotide. | GTP used in protein signaling. |
| G126 | GTT | Glucose Tolerance Test | Test for diabetes diagnosis. | GTT abnormal at 2 hours. |
| G127 | GTU | Genitourinary Tract | Urogenital system. | GTU imaging done in obstruction. |
| G128 | GU | Gastric Ulcer / Genitourinary | Stomach ulcer or urogenital tract. | GU bleeding noted on endoscopy. |
| G129 | GUA | Guanine | DNA base. | GUA mutation studied. |
| G130 | GUC | Gastric Ulcer Complication | Bleeding, perforation, etc. | GUC managed surgically. |
| G131 | GUD | Genital Ulcer Disease | STD-related condition. | GUD treated with antivirals. |
| G132 | GUS | Glucuronidase | Enzyme in metabolism. | GUS studied in lysosomal disorders. |
| G133 | GV | Graft Versus | Immune reaction post-transplant. | GV effect controlled with immunosuppressants. |
| G134 | GVA | General Visceral Afferent | Autonomic sensory fibers. | GVA studied in anatomy. |
| G135 | GVCF | Genomic Variant Call Format | Bioinformatics file format. | GVCF generated in WGS. |
| G136 | GVH | Graft-Versus-Host Disease | Complication post-transplant. | GVH treated with steroids. |
| G137 | GVL | Graft-Versus-Leukemia Effect | Beneficial immune effect. | GVL seen post bone marrow transplant. |
| G138 | GVP | Genetic Vaccine Platform | Modern vaccine approach. | COVID-19 trials used GVP. |
| G139 | GWAS | Genome-Wide Association Study | Genomics research method. | GWAS identified CAD risk loci. |
| G140 | GWI | Gulf War Illness | Chronic illness in veterans. | GWI studied in epidemiology. |
| G141 | GX | Genomic Expression | Transcriptomics output. | GX analyzed for cancer study. |
| G142 | GYN | Gynecology | Medical specialty. | GYN exam performed for infertility. |
| G143 | GYS | Glycogen Synthase | Enzyme in glycogen synthesis. | GYS deficiency linked to GSD. |
| G144 | GZMB | Granzyme B | Cytotoxic T-cell enzyme. | GZMB level measured in immunology. |
| G145 | GZR | Grazoprevir | Antiviral for hepatitis C. | GZR given with elbasvir. |
| G146 | Gα | G-Protein Alpha Subunit | Component of GPCR signaling. | Gα mutation studied in endocrinology. |
| G147 | Gβ | G-Protein Beta Subunit | GPCR signaling part. | Gβ measured in lab research. |
| G148 | Gγ | G-Protein Gamma Subunit | GPCR complex component. | Gγ studied in molecular medicine. |
| G149 | Gδ | Gamma Delta T Cells | Subset of T lymphocytes. | Gδ role in immunity researched. |
| G150 | Gε | Immunoglobulin E Heavy Chain | IgE-related notation. | Gε expressed in allergy studies. |
| G151 | Gζ | Zeta Chain of TCR | T-cell receptor component. | Gζ mutation linked to immune defects. |
| G152 | G1 | Gap 1 Phase (Cell Cycle) | First cell cycle phase. | G1 arrest induced by drug. |
| G153 | G2 | Gap 2 Phase (Cell Cycle) | Cell cycle pre-mitosis stage. | G2 checkpoint studied in oncology. |
| G154 | G3P | Glyceraldehyde-3-Phosphate | Glycolysis intermediate. | G3P detected in metabolism. |
| G155 | G4 | Guanine Quadruplex | DNA secondary structure. | G4 studied in cancer biology. |
| G156 | G12D | Glycine-12-Aspartate Mutation | KRAS oncogene mutation. | G12D mutation found in colon cancer. |
| G157 | GSK | GlaxoSmithKline | Pharma company. | GSK vaccine approved. |
| G158 | GSSG | Oxidized Glutathione | Oxidized form of GSH. | GSSG/GSH ratio measured in labs. |
| G159 | GSVT | Great Saphenous Vein Thrombosis | Clot in superficial leg vein. | GSVT treated with anticoagulants. |
| G160 | GTPase | Guanosine Triphosphatase | Enzyme hydrolyzing GTP. | GTPase studied in signaling pathways. |
| G161 | GNAS | GNAS Gene Mutation | Causes endocrine tumors. | GNAS mutation in McCune–Albright syndrome. |
| G162 | GPBB | Glycogen Phosphorylase Isoenzyme BB | Cardiac biomarker. | GPBB elevated in MI. |
| G163 | GREM | Gremlin Protein | BMP antagonist in development. | GREM overexpressed in cancer. |
| G164 | GUSB | Beta-Glucuronidase Gene | Enzyme-coding gene. | GUSB mutation caused storage disorder. |
| G165 | GYP | Glycophorin | RBC surface protein. | GYP variant studied in malaria. |
| G166 | GZF | Granulocyte Zinc Finger Protein | Transcription factor. | GZF role studied in cell growth. |
| G167 | GxP | Good Practice (GLP, GMP, GCP) | Regulatory guidelines. | Trial followed GxP standards. |
| G168 | Gd-EOB-DTPA | Gadolinium-Ethoxybenzyl-DTPA | MRI liver contrast agent. | Gd-EOB-DTPA used in HCC imaging. |
| G169 | Gd-DTPA | Gadolinium-Diethylenetriaminepentaacetic Acid | MRI contrast agent. | Gd-DTPA injected for MRI brain. |
| G170 | Gd-DO3A | Gadolinium-DO3A Complex | MRI contrast agent. | Gd-DO3A applied in kidney-safe imaging. |
| G171 | Gd-BOPTA | Gadolinium-BOPTA | MRI hepatobiliary contrast agent. | Gd-BOPTA scan performed. |
| G172 | Gd-HP-DO3A | Gadoteridol | MRI contrast agent. | Gd-HP-DO3A used in CNS imaging. |
| G173 | Gd-DOTA | Gadoterate Meglumine | MRI contrast agent. | Gd-DOTA administered IV. |
| G174 | Gd-BT-DO3A | Gadobutrol | High relaxivity MRI agent. | Gd-BT-DO3A chosen for vascular MRI. |
| G175 | Gd-DTPA-BMA | Gadodiamide | MRI contrast medium. | Gd-DTPA-BMA avoided in renal disease. |
| G176 | Gd-CA | Gadolinium Contrast Agent | MRI agents group. | Gd-CA used in MRI protocols. |
| G177 | GSK-3 | Glycogen Synthase Kinase 3 | Enzyme regulating glycogen. | GSK-3 inhibitors studied in diabetes. |
| G178 | GSN | Gelsolin | Actin-binding protein. | GSN mutation linked to amyloidosis. |
| G179 | GBA1 | Glucocerebrosidase Gene 1 | Gene for Gaucher’s disease. | GBA1 mutation tested. |
| G180 | GLA | Alpha-Galactosidase A | Enzyme deficient in Fabry’s disease. | GLA gene mutation sequenced. |
| G181 | GALK | Galactokinase | Enzyme in galactose metabolism. | GALK deficiency diagnosed. |
| G182 | GALM | Galactose Mutarotase | Enzyme in galactose metabolism. | GALM mutation reported. |
| G183 | GALT Deficiency | Galactose-1-Phosphate Uridyltransferase Deficiency | Classic galactosemia cause. | GALT enzyme test positive. |
| G184 | GLO1 | Glyoxalase I | Detox enzyme. | GLO1 expression studied in cancer. |
| G185 | GCLM | Glutamate Cysteine Ligase Modifier Subunit | Antioxidant enzyme. | GCLM variant studied in oxidative stress. |
| G186 | GCLC | Glutamate Cysteine Ligase Catalytic Subunit | Antioxidant enzyme. | GCLC mutation linked to GSH deficiency. |
| G187 | GSD-I | Glycogen Storage Disease Type I (von Gierke’s) | Inherited metabolic disorder. | GSD-I diagnosed in infant. |
| G188 | GSD-II | Glycogen Storage Disease Type II (Pompe’s) | Lysosomal storage disorder. | GSD-II treated with enzyme therapy. |
| G189 | GSD-III | Glycogen Storage Disease Type III (Cori’s) | Liver and muscle disorder. | GSD-III detected genetically. |
| G190 | GSD-IV | Glycogen Storage Disease Type IV (Andersen’s) | Rare glycogen branching defect. | GSD-IV diagnosed early. |
| G191 | GSD-V | Glycogen Storage Disease Type V (McArdle’s) | Muscle phosphorylase deficiency. | GSD-V presented with exercise cramps. |
| G192 | GSD-VI | Glycogen Storage Disease Type VI (Hers’) | Liver phosphorylase deficiency. | GSD-VI confirmed biochemically. |
| G193 | GSD-VII | Glycogen Storage Disease Type VII (Tarui’s) | PFK deficiency in muscle. | GSD-VII noted in exercise intolerance. |
| G194 | GSD-IX | Glycogen Storage Disease Type IX | Phosphorylase kinase deficiency. | GSD-IX mutation found. |
| G195 | GSD-0 | Glycogen Storage Disease Type 0 | Glycogen synthase deficiency. | GSD-0 showed fasting hypoglycemia. |
| G196 | GSD-X | Glycogen Storage Disease Type X | Rare variant. | GSD-X case reported. |
| G197 | GSD-XI | Glycogen Storage Disease Type XI | ENO3 deficiency. | GSD-XI case diagnosed. |
| G198 | GSD-XII | Glycogen Storage Disease Type XII | Aldolase A deficiency. | GSD-XII confirmed. |
| G199 | GSD-XIII | Glycogen Storage Disease Type XIII | Beta-enolase deficiency. | GSD-XIII rare case reported. |
| G200 | GSD-XIV | Glycogen Storage Disease Type XIV | Phosphoglucomutase deficiency. | GSD-XIV described genetically. |